Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC) Meeting Abstract


Authors: O'Reilly, E. M.; Lowery, M. A.; Segal, M. F.; Smith, S. C.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; Salo-Mullen, E. E.; Hollywood, E.; Epstein, A. S.; Capanu, M.; Moynahan, M. E.; Fusco, A.; Stadler, Z. K.; Do, R. K. G.; Chen, A. P.; Yu, K. H.; Tang, L. H.; Kelsen, D. P.
Abstract Title: Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613203186
PROVIDER: wos
Notes: Meeting Abstract: 4023 -- Source: Wos
MSK Authors
  1. Zsofia Kinga Stadler
    144 Stadler
  2. Marinela Capanu
    206 Capanu
  3. Maeve Aine Lowery
    96 Lowery
  4. Kenneth Ho-Ming Yu
    58 Yu
  5. Kinh Gian Do
    112 Do
  6. Andrew Saul Epstein
    68 Epstein
  7. Laura Hong Tang
    320 Tang
  8. Eileen O'Reilly
    316 O'Reilly
  9. David P Kelsen
    332 Kelsen
  10. Michal F Segal
    9 Segal
  11. Anne Fusco
    4 Fusco
  12. Sloane Camille Baptiste Smith
    6 Smith